← All indications
Behcet Syndrome
Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
Drugs by status
Phase 4 trials (8)
Phase 3 trials (8)
Phase 2 trials (22)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (18)
Organization Involved with Phase 2 Indications (19)
- Roche
- Hemay Pharmaceutical PTY. LTD.
- Amarillo Biosciences, Inc.
- Iltoo Pharma
- Nobel Pharmaceuticals
- National Eye Institute (NEI)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Cairo University
- Eskisehir Osmangazi University
- Indiana University
- New York University
- Istanbul University
- Peking University
- University of Cambridge
- Bilim University
- University of Paris
- Ipekyolu
- Silk Road Therapies, Inc.
- Shores Rheumatology
Organization Involved with Other Experimental Indications (7)